Nektar Therapeutics' President and CEO, Howard Robin, to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference
Nektar Therapeutics' President and CEO, Howard Robin, will present at the 39th Annual J.P.
Rhea-AI Summary
Nektar Therapeutics' President and CEO, Howard Robin, will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 11, 2021, at 11:50 a.m. PT. This presentation will include a Q&A session accessible via a Webcast available on the Nektar Investor Events Calendar. Interested individuals can access the replay until February 10, 2021. Nektar, headquartered in San Francisco, focuses on developing investigational medicines in oncology, immunology, and virology, alongside a portfolio of approved partnered medicines.
Details
News Market Reaction – NKTR
The recorded move for NKTR in the trading session of this news was +6.10%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Jan. 6, 2021 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin, is scheduled to present at the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 11:50 a.m. Pacific Time. The presentation and Q&A session will be accessible via a Webcast through a link posted on the Investor Events Calendar section of the Nektar website: https://ir.nektar.com/events-and-presentations/events. This webcast will be available for replay until February 10, 2021.
About Nektar
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
Contact:
For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661
For Media:
Dan Budwick of 1AB
973-271-6085
dan@1abmedia.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/nektar-therapeutics-president-and-ceo-howard-robin-to-present-at-the-39th-annual-jp-morgan-virtual-healthcare-conference-301202334.html
SOURCE Nektar Therapeutics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.